Arachidonic acid supplementation decreases P300 latency and increases P300 amplitude of event-related potentials in healthy elderly men

Neuropsychobiology. 2009;60(2):73-9. doi: 10.1159/000236447. Epub 2009 Sep 10.

Abstract

In the present study, we examined the effects of arachidonic acid (ARA) on age-related event-related potential (ERP) changes in 25 healthy elderly men. This study was performed using a double-blind crossover design. The subjects were administered 600 mg/day of ARA-enriched triglyceride (SUNTGA40S; containing 240 mg ARA) in capsules or the same amount of olive oil in capsules as an inactive placebo for 1 month. ERPs were measured before capsule administration and after 1 month of administration, and P300 latency and amplitude were also measured. In subjects administered 240 mg/day ARA, P300 latency was significantly shorter, and P300 amplitude was significantly higher than in those administered olive oil capsules, and they exhibited a significant increase in ARA content in serum phospholipids. These findings suggest that supplementation of ARA can improve cognitive function in healthy elderly men.

Publication types

  • Controlled Clinical Trial

MeSH terms

  • Aged
  • Analysis of Variance
  • Arachidonic Acid / administration & dosage*
  • Arachidonic Acid / blood
  • Brain / drug effects*
  • Brain / physiology
  • Cognition / drug effects*
  • Cognition / physiology
  • Cross-Over Studies
  • Dietary Supplements*
  • Double-Blind Method
  • Electroencephalography
  • Event-Related Potentials, P300 / drug effects*
  • Fatty Acids / administration & dosage
  • Fatty Acids / blood
  • Humans
  • Male
  • Middle Aged
  • Neuropsychological Tests
  • Nootropic Agents / administration & dosage*
  • Nootropic Agents / blood
  • Time Factors

Substances

  • Fatty Acids
  • Nootropic Agents
  • Arachidonic Acid